Episodic migraine affects a lot of people, yet the condition remains poorly understood. However, a team of researchers believes that it may have discovered a new biomarker for episodic migraine in the blood. The findings of the study, published in Neurology, could have implications for the diagnosis and treatment of episodic migraine if they can be supported by further research. "While more research is needed to confirm these initial findings, the possibility of discovering a new biomarker for migraine is exciting," reports study author Dr. B.
Lee Peterlin, of the Johns Hopkins University School of Medicine in Baltimore, MD. Episodic migraine is a headache disorder in which an individual has less than 15 headache days over the course of a month. In comparison, individuals with chronic migraine have 15 or more headache days per month. Migraines can have a significant impact on public…
